- Emerson Electric Co. EMR reported fourth-quarter net sales growth of 8.5% year-over-year to $4.95 billion, missing the consensus of $5.09 billion. Underlying sales were up 7%.
- Adjusted EPS improved to $1.21 from $1.10 in 4Q20, beating the consensus of $1.18.
- Sales by segments: Measurement & Analytical Instrumentation $860 million (+3.9% Y/Y), Valves, Actuators & Regulators $961 million (-1.9% Y/Y), Industrial Solutions $610 million (+12.6% Y/Y), Systems & Software $747 million (+14.1% Y/Y), Climate Technologies $1.29 billion (+16% Y/Y) and Tools & Home Products $486 million (+9.5% Y/Y).
- North America continued its strong recovery for the quarter despite supply chain challenges, with the Americas up 16%, while Europe was down 2%. Asia, Middle East & Africa was down 3%, with China up 10%.
- Pretax Margin of 16.7% down 10 bps and Adjusted EBIT Margin was 19%, down 30 bps.
- Emerson Electric's Operating Cash Flow was $3.6 billion (+16% Y/Y); Free Cash Flow was $3 billion, up 18%.
- 1Q22 Outlook: Emerson Electric expects net sales growth of 7% - 9%, with underlying sales growth of 7% - 9%. It expects an Adjusted EPS of $0.98 - $1.02 versus the consensus of $0.94.
- FY22 Outlook: Emerson Electric expects net sales growth of 5%-7%, with underlying sales growth of 6%-8%. It expects an Adjusted EPS of $4.82 - $4.97 versus the consensus of $4.57.
- Price Action: EMR shares are lower by 1.15% at $99 during the premarket session on Wednesday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in